MedPath

Evaluatie van een nieuwe optische beeldvormingstechniek voor de detectie van het mammacarcinoom bij patiënten met borstkanker.

Conditions
Breast cancer.
Registration Number
NL-OMON22989
Lead Sponsor
niversity Medical Center Groningen (UMCG), Department of Surgery.
Brief Summary

Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blachard DK, Fischer RE, Chiang SB, Elledge R, Mawad ME. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluophore: Feasibility study. Radiology 2008; 246: 734-741.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Women above the age of 18 who have biopsy-proven stage I-II breast cancer and who are planning to undergo lumpectomy as a treatment for their disease.

Exclusion Criteria

1. Refusal of the patient to be included in the study;

2. Pregnant or breast-feeding;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of this pilot study is the feasibility of intra-operative detection of breast carcinoma with an ICG enhanced optical imaging device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath